Rare diseases
Investigational molecules
Locations
Back to the Netherlands1 919 clinical trials in Leidschendam, The Netherlands across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.
Our site in the NetherlandsKlinischOnderzoek.nl(opens in a new tab)Study on the Effects of Psilocybin (COMP360) for Adults with Treatment-Resistant Depression
The NetherlandsStudy of MP0533 for Patients with Relapsed or Refractory Acute Myeloid Leukemia or Myelodysplastic Syndrome Using Sodium Dihydrogen Phosphate Dihydrate, Polysorbate 20, and Sodium Chloride
The NetherlandsStudy on the Effectiveness and Safety of Lebrikizumab for Adults and Adolescents with Moderate-to-Severe Atopic Dermatitis
The NetherlandsStudy on Dapagliflozin for Kidney Protection in Heart Transplant Patients
The NetherlandsStudy Comparing Ibrutinib and Venetoclax with Chlorambucil and Obinutuzumab for First-line Treatment in Patients with Chronic Lymphocytic Leukemia
The NetherlandsStudy of Lurbinectedin and Doxorubicin for First-line Treatment in Patients with Metastatic Leiomyosarcoma
The NetherlandsStudy on Upadacitinib for Children with Moderate to Severe Ulcerative Colitis
The NetherlandsStudy on the Long-Term Safety and Effectiveness of Upadacitinib for Patients with Moderate to Severe Crohn's Disease
The NetherlandsStudy of Inotuzumab Ozogamicin Alone and with Drug Combination for Children with Relapsed or Refractory Acute Lymphoblastic Leukemia
The NetherlandsStudy on Pembrolizumab, Lenvatinib, and Belzutifan for Patients with Liver, Colon, Pancreatic, Bile Duct, Gallbladder, Endometrial, or Esophageal Cancer
The NetherlandsStudy of Favezelimab Combined with Pembrolizumab (MK-4280A) for Patients with Selected Solid Tumors
The NetherlandsStudy of Belzutifan and Pembrolizumab for Patients with Renal Cell Carcinoma After Surgery
The NetherlandsThe busiest research cities in the country
What the registry says about research in the country
Multiple clinical trials focusing on non-small cell lung cancer (NSCLC) treatment advancements, evaluating novel therapeutic approaches including immunotherapy combinations and targeted treatments.
Studies compare various treatment options to improve patient outcomes and survival rates.
Comprehensive research into breast cancer treatments, particularly focusing on hormone receptor-positive and HER2-positive subtypes, investigating targeted therapies and chemotherapy combinations.
Trials examine innovative treatment strategies and personalized approaches.
Studies focusing on lymphoma treatments, including both Hodgkin and non-Hodgkin variants, evaluating response-adapted therapies and novel drug combinations.
Research aims to improve treatment outcomes while minimizing toxicity.
Investigations into colorectal cancer and related conditions, including innovative surgical approaches and treatment strategies for recurrent disease.
Focus on improving surgical outcomes and treatment effectiveness.
Studies examining treatment options for cerebral radiation necrosis and brain metastases, including innovative detection methods and therapeutic approaches.
Research aims to improve detection and treatment of brain metastases.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
